(S)-2-(Hydroxymethyl)morpholine hydrochloride is a chiral organic compound featuring a morpholine ring substituted with a hydroxymethyl group at the 2-position, in its (S)-enantiomeric form, and supplied as a hydrochloride salt. The morpholine ring is a saturated six-membered heterocycle containing both nitrogen and oxygen atoms, making this compound a versatile chiral building block. This compound is primarily utilized as a key chiral intermediate in pharmaceutical synthesis. Its structure combines a basic amine (protonated as the salt) with a primary alcohol functionality, allowing for diverse chemical modifications. It is notably employed in the research and development of active pharmaceutical ingredients (APIs), particularly those targeting the central nervous system and other therapeutic areas where the introduction of a chiral morpholine scaffold is desired to modulate biological activity, solubility, or pharmacokinetic properties. Due to its well-defined chirality and bifunctional nature, it serves as a valuable precursor for constructing more complex molecular architectures in medicinal chemistry. The hydrochloride salt form enhances its stability and handling characteristics.